Avalo Therapeutics, Inc. (AVTX) Net Income by Year
Avalo Therapeutics, Inc. reported a net loss of $78.3M in fiscal year 2025. This represents a decrease of 122.8% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Avalo Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AVTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
AVTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Avalo Therapeutics, Inc. financials
Frequently Asked Questions
What was Avalo Therapeutics, Inc.'s net income in fiscal year 2025?
Avalo Therapeutics, Inc. reported a net loss of $78.3M in fiscal year 2025.
How fast is Avalo Therapeutics, Inc.'s net income growing?
Avalo Therapeutics, Inc. (AVTX) net income fell by 122.8% year over year, from -$35.1M to -$78.3M in fiscal year 2025.
How has Avalo Therapeutics, Inc.'s net income changed over the years?
Across the 13 fiscal years this page covers, Avalo Therapeutics, Inc. (AVTX) net income went from -$13.0M in fiscal year 2013 to -$78.3M in fiscal year 2025.
What was Avalo Therapeutics, Inc.'s net income in the most recent quarter?
Avalo Therapeutics, Inc. (AVTX) reported -$36.4M in net income in Q2 2026. This represents a decrease of 75.1% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Avalo Therapeutics, Inc. (AVTX) reported on that line in every period on record.